We are live on ! Find out more
VAIA

Virtus Alternative Investment Advisers Portfolio holdings

AUM $6.71M
1-Year Est. Return 36.98%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+36.98%
3 Year Est. Return
+42.83%
5 Year Est. Return
10 Year Est. Return
AUM
$6.71M
AUM Growth
+$1.27M
Cap. Flow
+$345K
Cap. Flow %
5.15%
Top 10 Hldgs %
47.64%
Holding
286
New
20
Increased
6
Reduced
248
Closed
6

Top Sells

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$101K
2
MU icon
Micron Technology
MU
+$87K
3
MRK icon
Merck
MRK
+$66K
4
QCOM icon
Qualcomm
QCOM
+$50.6K
5
AVGO icon
Broadcom
AVGO
+$48K

Sector Composition

Rank Sector Weight
1 Industrials 16.11%
2 Technology 14.44%
3 Communication Services 14.32%
4 Healthcare 10.11%
5 Financials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
126
Idexx Laboratories
IDXX
$42.9B
$7K 0.1%
15
-15
-50% -$6.71K
IMVT icon
127
Immunovant
IMVT
$8.09B
$7K 0.1%
157
-152
-49% -$7.03K
JJSF icon
128
J&J Snack Foods
JJSF
$1.43B
$7K 0.1%
45
-43
-49% -$6.27K
LECO icon
129
Lincoln Electric
LECO
$13.8B
$7K 0.1%
63
-61
-49% -$6.68K
LMAT icon
130
LeMaitre Vascular
LMAT
$2.18B
$7K 0.1%
173
-167
-49% -$5.97K
MASI
131
DELISTED
Masimo
MASI
$7K 0.1%
26
-24
-48% -$5.99K
MGM icon
132
MGM Resorts International
MGM
$11.7B
$7K 0.1%
+220
New +$5.66K
MLAB icon
133
Mesa Laboratories
MLAB
$539M
$7K 0.1%
24
-23
-49% -$6.33K
MTD icon
134
Mettler-Toledo International
MTD
$26.8B
$7K 0.1%
6
-5
-45% -$5.48K
NYT icon
135
New York Times
NYT
$11.6B
$7K 0.1%
132
-127
-49% -$5.64K
OKTA icon
136
Okta
OKTA
$24.1B
$7K 0.1%
27
-25
-48% -$5.94K
POOL icon
137
Pool Corp
POOL
$6.7B
$7K 0.1%
18
-18
-50% -$6.28K
QLYS icon
138
Qualys
QLYS
$4.84B
$7K 0.1%
58
-56
-49% -$5.54K
RGEN icon
139
Repligen
RGEN
$7.44B
$7K 0.1%
39
-38
-49% -$6.91K
RHI icon
140
Robert Half
RHI
$3.61B
$7K 0.1%
107
-103
-49% -$6.15K
RMD icon
141
ResMed
RMD
$28.3B
$7K 0.1%
33
-31
-48% -$6.18K
RVTY icon
142
Revvity
RVTY
$12.3B
$7K 0.1%
47
-45
-49% -$5.99K
SNPS icon
143
Synopsys
SNPS
$71.5B
$7K 0.1%
27
-27
-50% -$6.23K
TDY icon
144
Teledyne Technologies
TDY
$30.4B
$7K 0.1%
18
-17
-49% -$6.1K
TECH icon
145
Bio-Techne
TECH
$11.2B
$7K 0.1%
92
-88
-49% -$6.37K
TFX icon
146
Teleflex
TFX
$5.85B
$7K 0.1%
17
-16
-48% -$5.9K
TREX icon
147
Trex
TREX
$4.51B
$7K 0.1%
82
-80
-49% -$6.12K
TTWO icon
148
Take-Two Interactive
TTWO
$43B
$7K 0.1%
34
-33
-49% -$5.77K
TXG icon
149
10x Genomics
TXG
$5.87B
$7K 0.1%
46
-44
-49% -$6.38K
TYL icon
150
Tyler Technologies
TYL
$12.2B
$7K 0.1%
16
-16
-50% -$6.6K

Similar funds

Virtus Alternative Investment Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Virtus Alternative Investment Advisers held 286 positions worth $6.71M, up 23% from $5.44M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Virtus Alternative Investment Advisers deployed $345K of net new capital in Q4 2020, opening 20 new positions and adding to 6 existing holdings. Its largest new stake was Invesco DB Gold Fund: 29,703 shares worth $1.64M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Watsco Inc, an estimated $101K trimmed.

  • Virtus Alternative Investment Advisers's largest Q4 2020 buy was Invesco DB Gold Fund: 29,703 shares worth $1.64M.
  • Virtus Alternative Investment Advisers added most to Charter Communications in Q4 2020, an estimated $148K increase.
  • Virtus Alternative Investment Advisers's biggest Q4 2020 reduction was Watsco Inc, cutting an estimated $101K.
  • Virtus Alternative Investment Advisers fully exited Merck in Q4 2020, selling an estimated $66K.
  • Virtus Alternative Investment Advisers's ten largest holdings make up 48% of its $6.71M portfolio in Q4 2020.
  • Virtus Alternative Investment Advisers opened 20 new positions and closed 6 in Q4 2020.
  • Virtus Alternative Investment Advisers's portfolio value rose 23% quarter-over-quarter to $6.71M.

Based on Virtus Alternative Investment Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.